Home > Insider Trading > Filing (0001209191-20-012619)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
917520	Integra Lifesciences Holdings Corp	IART	Surgical & Medical Instruments & Apparatus (3841)	510317849

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1323134	J Peter Arduini	1100 Campus Road Princeton NJ 08540	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-02-21	20,344	$13.89	262,919	No	4	M	Direct
Common Stock	Disposition	2020-02-21	20,344	$59.56	242,575	No	4	S	Direct
Common Stock	Acquisiton	2020-02-24	37,704	$13.89	280,279	No	4	M	Direct
Common Stock	Disposition	2020-02-24	37,704	$58.21	242,575	No	4	S	Direct
Common Stock	Acquisiton	2020-02-25	21,960	$13.89	264,535	No	4	M	Direct
Common Stock	Disposition	2020-02-25	21,960	$57.12	242,575	No	4	S	Direct
Common Stock	Acquisiton	2020-02-25	3,540	$13.89	246,115	No	4	M	Direct
Common Stock	Disposition	2020-02-25	3,540	$57.12	242,575	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-02-21	20,344	$0.00	20,344	$13.89
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-02-24	37,704	$0.00	37,704	$13.89
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-02-25	21,960	$0.00	21,960	$13.89
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-02-25	3,540	$0.00	3,540	$13.89

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
95,520	2020-03-01	No	4	M	Direct
57,816	2020-03-01	No	4	M	Direct
35,856	2020-03-01	No	4	M	Direct
32,316	2020-03-01	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
The price shown above represents the weighted average price of the shares sold. The range of sale prices was $59.50 to $60.29.
The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $57.57 to $58.86.
The price shown above represents the weighted average price of the shares sold. The range of sale prices was $56.50 to $58.43.
One-third of the stock options vested on the first anniversary of the grant date which is March 1, 2012 and thereafter with respect to the remaining two-thirds which vested in monthly installments throughthe 3rd anniversary of the grant date.